Liraglutide Increases the Catabolism of Apolipoprotein B100—Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression

Bibliographic Details
Title: Liraglutide Increases the Catabolism of Apolipoprotein B100—Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression
Authors: Vergès, B., Duvillard, L., de Barros, J. P. Pais, Bouillet, B., Baillot-Rudoni, S., Rouland, A., Petit, J. M., Degrace, P., Demizieux, L.
Source: Diabetes care. 44(4):1027-1037
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN626163202&indx=1&recIds=ETOCRN626163202
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:01495992
Published in:Diabetes care
Language:English